Furmonertinib-based triplet therapy improves survival in EGFR-mutant NSCLC with leptomeningeal metastases: a large-scale multicenter retrospective study (FURMO-LM)

H. Chen, H. Xu, Z. Yin, X. Li, G. Lin, T. Xin, H. Yang, Q. Zhao, W. Cheng, L. Zhang, H. Li, W. Xu, H. Zheng, C. Fan, F. Wang, L. Guo, Y. Wu, Y. Wu, S. Yang, X. Tang, C. Zhu, S. Fang, Q. Wang · 2026

Read Furmonertinib-based triplet therapy improves survival in EGFR-mutant NSCLC with leptomeningeal metastases: a large-scale multicenter retrospective study (FURMO-LM) by H. Chen, H. Xu, Z. Yin, X. Li, G. Lin, T. Xin, H. Yang, Q. Zhao, W. Cheng, L. Zhang, H. Li, W. Xu, H. Zheng, C. Fan, F. Wang, L. Guo, Y. Wu, Y. Wu, S. Yang, X. Tang, C. Zhu, S. Fang, Q. Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13264363.txt.

Description

H. Chen and a very large team analyze triple therapy for lung cancer spread to the membranes around the brain in a 2026 multicenter retrospective study. Six hundred eighteen patients with a targetable EGFR mutation received regimens built on the drug furmonertinib across many centers. Triple therapy added vessel-blocking treatment and chemotherapy, including delivery into spinal fluid for some, and outcomes were compared with single or double combinations for survival and time until treatment failed.

Median survival for the whole group sat a little over a year from treatment start. Triple therapy patients lived notably longer on median than those on simpler regimens. Side effects were catalogued across groups. Retrospective design limits causal claims, yet the scale gives rare guidance for a complication with few proven options.

Catalog record

CREATORH. Chen, H. Xu, Z. Yin, X. Li, G. Lin, T. Xin, H. Yang, Q. Zhao, W. Cheng, L. Zhang, H. Li, W. Xu, H. Zheng, C. Fan, F. Wang, L. Guo, Y. Wu, Y. Wu, S. Yang, X. Tang, C. Zhu, S. Fang, Q. Wang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13264363

Browse the full library · About the Tower of Babel